NEW YORK, June 9, 2016 /PRNewswire/ -- Attorney Advertising
-- Bronstein, Gewirtz & Grossman, LLC is investigating
potential claims on behalf of purchasers of the securities of
Insmed Incorporated ("Insmed" or the "Company") (NASDAQ:
INSM). Such investors are advised to contact Peretz Bronstein or his Investor Relations
Analyst Yael Hurwitz at
info@bgandg.com or 212-697-6484.
The investigation concerns whether Insmed and certain of its
officers and/or directors have violated Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934.
On June 8, 2016, post-market,
Insmed revealed that it had removed its European marketing
application from the European Medicines Agency ("EMA") for its lung
disease drug Arikayce. Insmed said its data from a mid-stage
clinical study that was not sufficient proof for EMA approval.
Insmed said it would resubmit its application at a later time
when there is more data. Following this news, Insmed stock
dropped $2.20 per share, or more than
18% to $9.80 in after-hours
trading.
If you are aware of any facts relating to this investigation, or
purchased shares of Insmed, you can assist this investigation by
visiting the firm's site: http://www.bgandg.com/#!insm/iz8zm or by
contacting Peretz Bronstein or his
Investor Relations Analyst, Yael
Hurwitz of Bronstein, Gewirtz & Grossman, LLC at
212-697-6484 or via email info@bgandg.com. Those who inquire
by e-mail are encouraged to include their mailing address, email
and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-insmed-incorporated-insm-300282424.html
SOURCE Bronstein, Gewirtz & Grossman, LLC